Position in DERM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$140,202
+$84,782 QoQ
Shares Held
29,894
+98.5% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. DERM ranks #15 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
154,970 | $4,667,696 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
188,802 | $4,659,633 | |
| 3 | CRON |
Cronos Group Inc.
|
1,500,000 | $3,765,000 | |
| 4 | LQDA |
Liquidia Corp
|
40,595 | $1,532,055 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,345 | $1,390,538 | |
| 6 | VTRS |
Viatris Inc
|
102,186 | $1,380,532 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
50,735 | $1,146,611 | |
| 8 | ALKS |
Alkermes plc.
|
16,928 | $598,574 |
All Filings in DERM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $140,202 | 29,894 | Shares | Other | 2026-05-15 | |
| 2024-03-31 | $55,420 | 15,060 | Shares | Other | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||